Nairismägi, M. -L.
~ 0  Ergebnisse:
Personensuche X
?
1

Clinical Targeted Next-Generation Sequencing to Identify Po..:

Poon, S.L. ; Lu, Y.-J. ; Jhou, R.-S....
Journal of Global Oncology.  4 (2018)  Supplement 2 - p. 88s-88s , 2018
 
?
3

Application of a Cancer Hotspot Panel to Guide Lung Cancer ..:

Nairismägi, M.-L. ; Tung, K.-C. ; Yang, Y.-T....
Journal of Global Oncology.  4 (2018)  Supplement 2 - p. 35s-35s , 2018
 
?
4

ONCOGENIC ACTIVATION OF STAT3 PATHWAY DRIVES PD‐L1 EXPRESSI..:

Song, T. ; Nairismagi, M. ; Lim, J....
Hematological Oncology.  35 (2017)  S2 - p. 163-164 , 2017
 
?
5

Abrogation of JAK/STAT Pathway in Radiosensitization of NK/..:

Lie, S. ; Ong, C.K. ; Tan, J....
International Journal of Radiation Oncology*Biology*Physics.  96 (2016)  2 - p. E492-E493 , 2016
 
?
 
?
8

41 Genome-wide mutational signatures of aristolochic acid i..:

Poon, S.L. ; Pang, S-T. ; McPherson, J.R....
European Urology Supplements.  13 (2014)  1 - p. e41-e41a , 2014
 
?
9

Genetic drivers of oncogenic pathways in molecular subgroup..:

Heavican, Tayla B ; Bouska, Alyssa ; Yu, J...
https://pure.au.dk/portal/da/publications/genetic-drivers-of-oncogenic-pathways-in-molecular-subgroups-of-peripheral-tcell-lymphoma(c36deca9-bc03-44ba-87a4-eeb61498c32d).html.  , 2019
 
?
10

JAK-STAT and G-protein-coupled receptor signaling pathways ..:

Nairismägi, M-L ; Tan, J ; Lim, J Q...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895162/.  , 2016
 
1-10